Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
US Market
Holding ARCT?
Track your performance easily

Arcturus Therapeutics (ARCT) Financial Statements

1,518 Followers

Arcturus Therapeutics Financial Overview

Arcturus Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.568; its P/E ratio is -7.01; Arcturus Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-1.22. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 49.86M$ 38.01M$ 25.08M$ 45.14M$ 10.52M
Gross Profit$ 49.86M$ 38.01M$ 30.86M$ 45.14M$ 10.52M
EBIT$ -17.37M$ -26.45M$ -11.44M$ -15.33M$ -51.97M
EBITDA$ -16.46M$ -25.55M$ -10.63M$ -14.50M$ -51.24M
Net Income Common Stockholders$ -17.22M$ -26.82M$ -11.71M$ -16.22M$ -52.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 260.33M$ 288.40M$ 292.00M$ 311.92M$ 323.47M
Total Assets$ 388.61M$ 418.85M$ 429.40M$ 457.65M$ 430.65M
Total Debt$ 26.96M$ 27.65M$ 25.91M$ 47.02M$ 28.11M
Net Debt$ -233.37M$ -260.74M$ -266.10M$ -264.90M$ -295.36M
Total Liabilities$ 130.03M$ 154.88M$ 150.89M$ 177.59M$ 145.47M
Stockholders Equity$ 258.58M$ 263.97M$ 278.51M$ 280.06M$ 285.21M
Cash Flow-
Free Cash Flow$ -30.47M$ -5.80M$ -1.50M$ -33.39M$ 50.45M
Operating Cash Flow$ -30.14M$ -5.56M$ -629.00K$ -32.41M$ 50.81M
Investing Cash Flow$ -328.00K$ -240.00K$ -875.00K$ -981.00K$ -354.00K
Financing Cash Flow$ 2.40M$ 2.19M$ -18.66M$ 21.84M$ 94.00K
Currency in USD

Arcturus Therapeutics Earnings and Revenue History

Arcturus Therapeutics Debt to Assets

Arcturus Therapeutics Cash Flow

Arcturus Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis